Last update 07 Nov 2024

Lifastuzumab vedotin

Overview

Basic Info

Drug Type
Antibody drug conjugate (ADC)
Synonyms
ANTI-NAPI2B, Lifastuzumab vedotin (USAN/INN), DNIB-0600A
+ [5]
Mechanism
NaPi-2b inhibitors(Sodium-dependent phosphate transport protein 2B inhibitors), Tubulin inhibitors
Active Indication-
Originator Organization
Active Organization-
Inactive Organization
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC39H67N5O7
InChIKeyDASWEROEPLKSEI-UIJRFTGLSA-N
CAS Registry474645-27-7
View All Structures (2)
Boost your research with our XDC technology data.
Boost your research with our XDC technology data.

External Link

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Platinum-Resistant Ovarian CarcinomaPhase 2
US
06 Feb 2014
Platinum-Resistant Ovarian CarcinomaPhase 2
BE
06 Feb 2014
Platinum-Resistant Ovarian CarcinomaPhase 2
CA
06 Feb 2014
Platinum-Resistant Ovarian CarcinomaPhase 2
FR
06 Feb 2014
Platinum-Resistant Ovarian CarcinomaPhase 2
PL
06 Feb 2014
Platinum-Resistant Ovarian CarcinomaPhase 2
ES
06 Feb 2014
Platinum-Resistant Ovarian CarcinomaPhase 2
GB
06 Feb 2014
Fallopian Tube CarcinomaPhase 2
US
-
Fallopian Tube CarcinomaPhase 2
BE
-
Fallopian Tube CarcinomaPhase 2
CA
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free